counterfeit semaglutide legal status fda issued 25 warning letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Warning: Fake weight loss drugs

J., Searson, P

Robust quality control for GHK Cu typically includes Identity testing, often by MS or LC MS, and sometimes FTIR or NMR Purity testing, often by HPLC, with chromatograms available Assay or potency information, describing how much active material is present in the lot Ignoring copper chemistry Copper is both useful and reactive

Key end points included: hospitalisation, heart failure (ICD-10-CM-I50), myocardial infarction (ICD-10-CM-I21), stroke and transient ischaemic attack (ICD-10-CM-I63, G45), development of diabetic microvascular complications (ICD-10-CM-E10.210.4) and all-cause mortality analysed 3 months to 5 years post drug initiation

Following GLP-1 deprescription, patients weight did not significantly increase at 6 or 12 months post deprescription, compared to many well-known drug trials (in red) where patients regain up to two thirds of weight loss after discontinuing the drug